Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Envoy Medical to Present at the Small Cap Growth Virtual Investor Conference February 5

globenewswire.com
COCH The article announces that Envoy Medical will present at an investor conference. This is a routine corporate event and does not provide specific information about the company's performance or future prospects, hence the neutral sentiment.

WHITE BEAR LAKE, Minn., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Envoy Medical® Inc. (NASDAQ: COCH) (“Envoy Medical” or the “Company”), a hearing health company pioneering fully implanted hearing solutions, today announced that management will participate in the Small Cap Growth Virtual Investor Conference on February 5, 2026.

Small Cap Growth Virtual Investor Conference Presentation Details:

Date: Thursday, February 5, 2026

Time: 10:00 A.M. ET

REGISTER HERE

A question-and-answer session will follow the presentation, during which investors may submit questions in real time. If attendees are not able to join the live event, a link to the recording will be available on Envoy’s Investor Relations website after the event.

About Envoy Medical, Inc.

Envoy Medical (NASDAQ: COCH) is a hearing health company focused on providing innovative technologies across the hearing loss spectrum. Envoy Medical has pioneered one-of-a-kind, fully implanted devices for hearing loss, including its fully implanted Esteem® active middle ear implant, commercially available in the U.S. since 2010, and the fully implanted Acclaim® cochlear implant, an investigational device.

CAUTION

The fully implanted Acclaim Cochlear Implant is an investigational device. Limited by Federal (or United States) law to investigational use.